{"groups":[{"description":"Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks.\n\ncyproheptadine hydrochloride: Given orally","id":"FG000","title":"Arm I Cyproheptadine Hydrochloride"},{"description":"Patients receive an oral placebo twice daily for 8 weeks.\n\nplacebo: Given orally","id":"FG001","title":"Arm II Placebo"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"1"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"13"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"12"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}